Navigation Links
deCODE discovers genetic markers that improve the power of PSA testing for detecting prostate cancer
Date:12/15/2010

Reykjavik, ICELAND, 15 December 2010 Scientists from deCODE genetics and academic colleagues from Iceland, the UK, US, Netherlands, Spain and Romania today report the discovery of a set of single-letter variations in the sequence of the human genome (SNPs) that impact individual baseline levels of prostate specific antigen, or PSA. Testing for PSA levels is the most commonly used screening tool for the detection of prostate cancer. A prostate biopsy is routinely recommended for men with PSA above a certain threshold. However, PSA levels can rise for reasons unrelated to prostate cancer and baseline healthy levels vary substantially between individuals, resulting in many men without cancer being biopsied while cancer in others is not detected. The paper published today demonstrates that analysis of four SNPs can be used to derive a personalized PSA threshold that more accurately identifies those men who are more likely to have a positive biopsy and for whom one should therefore be recommended.

"This is straighforward genetics with direct clinical utility. Detected early, prostate cancer can be treated with near total success. The challenge is to more effectively risk stratify the population, identifying and biopsying those at high risk and with aggressive disease while minimizing the number of negative biopsies we perform. And using the genetics we are improving the sensitivity and specificity of PSA testing. Like virtually every protein in the body, PSA levels vary between individuals according to SNPs that regulate gene expression. The SNPs reported today enable us to personalize PSA thresholds, thereby changing the recommendation on whether to biopsy for a substantial proportion of men. Moreover, the discriminatory power of testing for these SNPs is highest when done in tandem with the SNPs associated directly with risk of the disease measured by our deCODE ProstateCancer test. We are working to swiftly incorporate these PSA markers into our tes
'/>"/>

Contact: Edward Farmer
edward.farmer@decode.is
354-863-1923
deCODE genetics
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Scientists decode secrets of a very common virus that can cause cancer
2. Physicists use graphene to decode DNA
3. The language of RNA decoded: Study reveals new function for pseudogenes and noncoding RNAs
4. UT professor defines play, discovers even turtles need recess
5. Research discovers how the deaf have super vision
6. Colorado researcher discovers mechanism for changing adult cells into stem-like cells
7. Researcher at Childrens Hospital LA discovers way to overcome radiation resistance in leukemia
8. TGen-Mayo Clinic study discovers role of DNA methylation in multiple myeloma blood cancer
9. Virginia Tech professor discovers new TB pathogen
10. UCSF-led team discovers familial link in rare childhood leukemia
11. UR discovers new way to boost vaccines, seeks patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... 30, 2015 , ... Between 2012 and 2014 HIV infection rates rose from ... on June 17th. Those untreated heroin use disorders share their needles and spread the ... needles throughout the community. Ultimately Florida’s HIV infection rates have bolstered to 23 percent ...
(Date:7/30/2015)... ... 30, 2015 , ... Ocean Hills Recovery has officially been accredited by CARF ... No recommendations means CARF found no areas in the OHR program that needed improvement, ... of all facilities receive. In addition, Ocean Hills was granted the maximum certification period ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... Administration (DEA) Acting Administrator Chuck Rosenberg’s announcement of the reinstitution of National Prescription ... Saturday, September 26, 2015 from 10:00 AM to 2:00 PM local time. On ...
(Date:7/30/2015)... ... July 30, 2015 , ... The Tisch Cancer ... Designation , The Tisch Cancer Institute (TCI) at the Icahn School of Medicine ... TCI joins an elite group of 69 cancer institutions nationwide that have earned ...
(Date:7/30/2015)... , ... July 30, 2015 , ... InventHelp, ... Texas, has designed a personal-care device that makes it easy to apply lotion or ... eliminate the need for assistance when applying lotion or medication to the back, and ...
Breaking Medicine News(10 mins):Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 2Health News:HIV Rates Rise in S. Florida, Harbor Village Comments on Health News Florida's Recent Article 3Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:InventHelp® Client Patents “My Back Buddy” – Device Could Apply Lotion to Hard-to-Reach Areas Easily 2
... been characterized as the most materialistic generation in history: ... owning luxury handbags and the latest technology devices. ... of teen materialism. In fact, research suggests that parents ... therefore, highly materialistic parents and peers are likely to ...
... ... headquartered in Nashville must pay $19.4 million plus interest to the United States government after ... , ... 2010 -- United States District Court Judge William J. Haynes, Jr. issued an order on ...
... ... Center School of Medicine has designed a first-of-its-kind program to alleviate ... Track (FMAT), has been approved by the Liaison Committee for Medical ... will complete their training one year earlier than students in the ...
... ... a new effort by Congress to reduce pharmacy choices, arbitrarily set prices, ... program. FEHBP enrollees feel that OPM does a great job managing ... the program by forcing OPM to change FEHBP’s pharmacy benefits. This was ...
... for some patients with operable disease, review finds , ... for patients with operable non-small cell lung cancer, say ... meta-analysis of 34 studies involving almost 8,500 patients (and ... years was 64 percent for patients who had chemotherapy ...
... Tuesday, President Obama signed into law U.S. health care ... affect them, their families, and businesses. The ... 2006 legislation in Massachusetts requiring all adults in the ... mandate. A new article from The Milbank Quarterly ...
Cached Medicine News:Health News:Counteracting teens' logo lust 2Health News:Fresenius Medical Holdings, Inc. Ordered To Pay $19.4 Million For Fraudulent Medicare Claims 2Health News:Fresenius Medical Holdings, Inc. Ordered To Pay $19.4 Million For Fraudulent Medicare Claims 3Health News:Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution 2Health News:Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution 3Health News:Primary Care Physician Shortage: Texas Tech University Health Sciences Center Has the Solution 4Health News:PCMA: Federal Enrollees Don't Want Congress to Reduce Pharmacy Choices, Impose Price Controls in FEHBP 2Health News:Chemo May Boost Survival After Lung Cancer Surgery 2Health News:Massachusetts health care reform reviewed as a model for national plan 2
(Date:7/30/2015)... ATLANTA , July 30, 2015  Big ... real-time predictive analytics technology, announces it is working ... (IoT) solutions for the new Lockheed Martin Healthcare ... of leading health information technology providers, medical technology ... foster collaboration and innovation to improve care in ...
(Date:7/30/2015)... July 30, 2015  Cleave Biosciences today announced ... has granted the company a key patent providing ... molecule CB-5083. This newly issued patent, ... p97," U.S. 9,062,026, allows for claims on the ... selective oral inhibitor of p97, a critical enzyme ...
(Date:7/30/2015)... 2015 EnteroMedics Inc. (NASDAQ: ETRM ), ... treat obesity, metabolic diseases and other gastrointestinal disorders, today ... Thursday, August 6, 2015, at 11:00 AM Eastern Time ... June 30, 2015, and to provide an update on ... via the Maestro® System. Conference Call Details ...
Breaking Medicine Technology:Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 2Big Cloud Analytics Develop Internet of Things (IoT) Solutions with Intel Supporting Launch of Lockheed Martin Healthcare Technology Alliance 3EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 2EnteroMedics to Host Second Quarter 2015 Financial Results and Company Update Conference Call 3
... 11, 2011 CrystalGenomics, Inc., a biopharmaceutical company with ... draft Clinical Study Report (CSR) from CG400549,s Phase I ... CG400549 is a potential first-in-class antibiotic candidate ... enzyme in generating bacterial membrane and has a novel ...
... Corporation (NASDAQ: LIFE ) announced today that ... all of the outstanding 3.25% Convertible Senior Notes due ... As of May 6, 2011 there was $350,000,000 in ... The redemption notice provided includes CUSIP Numbers: 46185RAL4 and ...
Cached Medicine Technology:CrystalGenomics Completes Phase I MAD Study of its Novel Antibiotic Candidate CG400549, and Prepares for Phase II Clinical Study 2Life Technologies Announces Redemption of 3.25% Convertible Senior Notes Due 2025 2
... Lensmeter is designed for fast and easy ... Auto mode, the readings are automatically held ... lenses are automatically detected. The sophisticated alignment ... lens. The TL-2000A has been designed with ...
The Kowa Pro-lll is Kowas' flagship camera....
The new CR6-45NM non-mydriatic retinal camera is an ideal diagnostic tool for ophthalmologists, optometrists and other medical professionals, especially when it comes to detecting and monitoring diab...
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
Medicine Products: